Refine
Has Fulltext
- yes (13)
Is part of the Bibliography
- yes (13)
Document Type
- Journal article (13)
Language
- English (13) (remove)
Keywords
- COVID-19 (3)
- SARS-CoV-2 (3)
- adaptation (2)
- evolution (2)
- positive selection (2)
- recombination (2)
- Aspergillus fumigalus (1)
- Aspergillus fumigatus (1)
- CD4+ T-cells (1)
- CLAVATA3 (1)
- CLV3p (1)
- DNA storage (1)
- FLS2 receptor (1)
- NSG animals (1)
- T-cell epitope (1)
- alveolar fibrosis (1)
- alveolar regeneration (1)
- annotation (1)
- antimycotics (1)
- auxin (1)
- cancer metabolism (1)
- cell death (1)
- comparative sequence analysis (1)
- controllability (1)
- cycle (1)
- cytokinins (1)
- database (1)
- defense signaling (1)
- dendritic cells (1)
- drosophila (1)
- drug repurposing (1)
- dynamic protein-protein interactions (1)
- epitope prediction (1)
- evolutionary (1)
- fostamatinib (1)
- fungicide (1)
- genus Aspergillus (1)
- human pathogenic fungi (1)
- identification (1)
- immune-informatics (1)
- immunosenescence (1)
- infection (1)
- inflammaging (1)
- interaction (1)
- interaction map (1)
- intermediate host (1)
- lymphocytes (1)
- meta-transcriptome (1)
- metabolic modelling (1)
- metabolism (1)
- modeling (1)
- molecular evolution (1)
- mutation (1)
- myocardial aging (1)
- network biology (1)
- network simulation (1)
- oncolytic virus (1)
- optogenetics (1)
- origin (1)
- pangolin (1)
- phylogenetic analysis (1)
- platelet (1)
- protein analysis (1)
- reliability (1)
- shoot apical meristem (1)
- signaling network (1)
- signaling pathway (1)
- signalling (1)
- signalling pathways (1)
- stem cell niche (1)
- stem-cell-triggered immunity (1)
- structure (1)
- system inference (1)
- target (1)
- target validation (1)
- targeted therapies (1)
- targets (1)
- transmission (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (11)
- Institut für Molekulare Infektionsbiologie (4)
- Center for Computational and Theoretical Biology (2)
- Institut für Experimentelle Biomedizin (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Institut für Informatik (1)
- Medizinische Klinik und Poliklinik I (1)
- Medizinische Klinik und Poliklinik II (1)
- Pathologisches Institut (1)
- Rudolf-Virchow-Zentrum (1)
Introduction
Pro-thrombotic events are one of the prevalent causes of intensive care unit (ICU) admissions among COVID-19 patients, although the signaling events in the stimulated platelets are still unclear.
Methods
We conducted a comparative analysis of platelet transcriptome data from healthy donors, ICU, and non-ICU COVID-19 patients to elucidate these mechanisms. To surpass previous analyses, we constructed models of involved networks and control cascades by integrating a global human signaling network with transcriptome data. We investigated the control of platelet hyperactivation and the specific proteins involved.
Results
Our study revealed that control of the platelet network in ICU patients is significantly higher than in non-ICU patients. Non-ICU patients require control over fewer proteins for managing platelet hyperactivity compared to ICU patients. Identification of indispensable proteins highlighted key subnetworks, that are targetable for system control in COVID-19-related platelet hyperactivity. We scrutinized FDA-approved drugs targeting indispensable proteins and identified fostamatinib as a potent candidate for preventing thrombosis in COVID-19 patients.
Discussion
Our findings shed light on how SARS-CoV-2 efficiently affects host platelets by targeting indispensable and critical proteins involved in the control of platelet activity. We evaluated several drugs for specific control of platelet hyperactivity in ICU patients suffering from platelet hyperactivation. The focus of our approach is repurposing existing drugs for optimal control over the signaling network responsible for platelet hyperactivity in COVID-19 patients. Our study offers specific pharmacological recommendations, with drug prioritization tailored to the distinct network states observed in each patient condition. Interactive networks and detailed results can be accessed at https://fostamatinib.bioinfo-wuerz.eu/.
PRO-Simat is a simulation tool for analysing protein interaction networks, their dynamic change and pathway engineering. It provides GO enrichment, KEGG pathway analyses, and network visualisation from an integrated database of more than 8 million protein-protein interactions across 32 model organisms and the human proteome. We integrated dynamical network simulation using the Jimena framework, which quickly and efficiently simulates Boolean genetic regulatory networks. It enables simulation outputs with in-depth analysis of the type, strength, duration and pathway of the protein interactions on the website. Furthermore, the user can efficiently edit and analyse the effect of network modifications and engineering experiments. In case studies, applications of PRO-Simat are demonstrated: (i) understanding mutually exclusive differentiation pathways in Bacillus subtilis, (ii) making Vaccinia virus oncolytic by switching on its viral replication mainly in cancer cells and triggering cancer cell apoptosis and (iii) optogenetic control of nucleotide processing protein networks to operate DNA storage. Multilevel communication between components is critical for efficient network switching, as demonstrated by a general census on prokaryotic and eukaryotic networks and comparing design with synthetic networks using PRO-Simat. The tool is available at https://prosimat.heinzelab.de/ as a web-based query server.
Dendritic cells (DCs) are antigen presenting cells which serve as a passage between the innate and the acquired immunity. Aspergillosis is a major lethal condition in immunocompromised patients caused by the adaptable saprophytic fungus Aspergillus fumigatus. The healthy human immune system is capable to ward off A. fumigatus infections however immune-deficient patients are highly vulnerable to invasive aspergillosis. A. fumigatus can persist during infection due to its ability to survive the immune response of human DCs. Therefore, the study of the metabolism specific to the context of infection may allow us to gain insight into the adaptation strategies of both the pathogen and the immune cells. We established a metabolic model of A. fumigatus central metabolism during infection of DCs and calculated the metabolic pathway (elementary modes; EMs). Transcriptome data were used to identify pathways activated when A. fumigatus is challenged with DCs. In particular, amino acid metabolic pathways, alternative carbon metabolic pathways and stress regulating enzymes were found to be active. Metabolic flux modeling identified further active enzymes such as alcohol dehydrogenase, inositol oxygenase and GTP cyclohydrolase participating in different stress responses in A. fumigatus. These were further validated by qRT-PCR from RNA extracted under these different conditions. For DCs, we outlined the activation of metabolic pathways in response to the confrontation with A. fumigatus. We found the fatty acid metabolism plays a crucial role, along with other metabolic changes. The gene expression data and their analysis illuminate additional regulatory pathways activated in the DCs apart from interleukin regulation. In particular, Toll-like receptor signaling, NOD-like receptor signaling and RIG-I-like receptor signaling were active pathways. Moreover, we identified subnetworks and several novel key regulators such as UBC, EGFR, and CUL3 of DCs to be activated in response to A. fumigatus. In conclusion, we analyze the metabolic and regulatory responses of A. fumigatus and DCs when confronted with each other.